Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Radiofrequency Therapy in Management of Sickle Cell Disease Chronic Pain

NCT07066072 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT07066072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07066072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Radiofrequency Therapy in Management of Sickle Cell Disease Chronic Pain
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2022
Completion date
March 30, 2025
Enrollment
170 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the use of radiofrequency ablation in form of tecar(capacitive and resistive transfer energy) in chronic pain of sickle cell disease patients